Jeanette E. Spaghetti

Monsanto Looking At “Strategic Options” After Rejecting Bayer’s $62B Bid

A month after Monsanto deemed a $62 billion proposed merger bid from Bayer “financially inadequate,” the Missouri seed and pesticide giant is reportedly looking at its options after receiving less-than-stellar earning numbers.  [More]

Monsanto Says $62 Billion Bayer Merger Offer Is “Financially Inadequate”

Monsanto Says $62 Billion Bayer Merger Offer Is “Financially Inadequate”

A day after aspirin king Bayer officially offered $62 billion to acquire Missouri seed and pesticide giant Monsanto, the deal already appears troubled, with Monsanto’s board of directors saying the offer isn’t sufficient. [More]

Jeanette E. Spaghetti

Bayer Officially Offers $62B For Monsanto

Bayer officially wants to expand its CropSciences business and become the world’s largest producer of seeds, pesticides and agricultural chemicals, bidding $62 billion for Monsanto. [More]

Jeanette E. Spaghetti

Bayer Reportedly Looking To Acquire Monsanto For $40 Billion

When you hear the name Bayer, you probably think of aspirin or other drugs, but the German company has a number of facets, including its sizable CropScience division that produces seeds, pesticides, and other agricultural products. Now comes news that Bayer may be looking to become the world’s largest player in this field (forgive the pun) with a possible acquisition of Monsanto. [More]

The enemy: pollen. (Karen Chappell)

Big Data Predicts Pollen Levels, Keeps Allergy Medicines In Stock

Here in the Northeast, people who are allergic to pollen are having a harsh spring. They should take comfort, though, that there isn’t a corresponding shortage of allergy medicines, as there apparently was five years ago. Drug companies have learned how to take global climate data and turn it into more plentiful antihistamines when people need them. [More]

According to the complaint, Bayer does not have sufficient science to back up many of its health claims on its One A Day Multivitamins.

Bayer Sued Over Allegedly Misleading Marketing Of One-A-Day Vitamins

The marketing for Bayer’s One A Day brand of multivitamins makes some very specific claims about what these products can do to improve a user’s health. But a new lawsuit brought against the over-the-counter drug giant argues that Bayer’s statements aren’t always backed up by the science necessary to make those claims. [More]

(Earth2Kim)

Milk, Aspirin, Broadband, And LivingSocial: Some Class Actions You Might Be Eligible For

Organic milk, LivingSocial vouchers, Norton Antivirus, Verizon Wireless games, and Clearwire Internet service: what do they all have in common? All of these companies have open class-action lawsuits against them for which eligible customers can file claims and get cash. [More]

(SA_Steve)

Lawsuit Accuses Big Pharma Of Using Bogus Expiration Dates To Trick Customers Into Buying More Meds

When it comes to over-the-counter pain pills, many people don’t even think to look at the expiration date on the side of the bottle. But a new class-action lawsuit claims that three of the biggest names in the (legal) drug business are deliberately putting early expiration dates on their products to encourage customers to throw them out and buy new ones. [More]

Dosage Instructions For One A Day Vitamin Gummies: Take Two A Day

Dosage Instructions For One A Day Vitamin Gummies: Take Two A Day

One A Day is a well-known brand of vitamins, but its name is just that. A name. A brand. Not dosage instructions. This caught Jeff by surprise, though, when he bought a bottle of the brand’s Vita-Crave gummy vitamins for adults. He opened the bottle to find it half full: pretty normal for bottles of pills and supplements, but still irksome. Then he noticed the instructions on the bottle: take two per day. Take two One A Day gummies. I see. [More]

Bayer Says They've Paid Out $142 Million In Yasmin Birth Control Settlements So Far

Bayer Says They've Paid Out $142 Million In Yasmin Birth Control Settlements So Far

Bayer says they’ve been shelling out some serious dough, $142 million to be exact, to settle around 651 U.S. cases involving their Yasmin and Yaz birth control pills. Consumers in those cases allege that the pills caused blood clots, which can sometimes be fatal or lead to heart attacks and strokes. That’s around $218,000 per woman, on average. [More]

Xenadrine, TrimSpa, CortiSlim, One-A-Day Makers to Pay $26 Million

Xenadrine, TrimSpa, CortiSlim, One-A-Day Makers to Pay $26 Million

    Bayer AG and several smaller companies agreed to pay the U.S. government almost $26 million to settle allegations of false weight-loss advertising claims, the Federal Trade Commission said on Thursday.

This is Not News: Bayer Knowingly Sold AIDS Infected Drugs

We were shocked yesterday to see this clip accusing Bayer of selling medicine they knew was infected with AIDS, but maybe we should’ve been shocked back in the mid 80’s.